Abstract:Dengue is now a global burden with about 3.97 billion people living in 128 countries at risk and 400 million infections occurring every year. Four closely related serotypes have been implicated in the global burden: DENV 1-4. It has been reported that there are serotype specific differences in clinical manifestations. This systematic review is based on PRISMA guidelines. It discusses two types of DENV vaccine based on inclusion criteria: Tetravalent dengue vaccine (TDV) and dengue DNA vaccine that are in clini… Show more
Set email alert for when this publication receives citations?
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.